In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ATAZANAVIR SULPHATE Drug Master File in Korea (ATAZANAVIR SULPHATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ATAZANAVIR SULPHATE. The MFDS reviews the ATAZANAVIR SULPHATE KDMF as part of the drug registration process and uses the information provided in the ATAZANAVIR SULPHATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a ATAZANAVIR SULPHATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ATAZANAVIR SULPHATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ATAZANAVIR SULPHATE suppliers with KDMF on PharmaCompass.